Multiple Sclerosis Channel
Topics & Medications
Quicklinks
Related Channels

Tysabri Pregnancy Category

Although Tysabri® (natalizumab) has not been adequately studied in pregnant women, this drug caused miscarriages and blood cell problems in the offspring when it was given to pregnant animals. As a result of these complications, the U.S. Food and Drug Administration (FDA) classified Tysabri as a pregnancy Category C drug.
 
A pregnancy Category C medicine, such as Tysabri, should only be given to a pregnant woman if the healthcare provider believes that the benefits to the woman outweigh any possible risks to her unborn child.
 
(For more details on the risks of receiving this drug during pregnancy, click Tysabri and Pregnancy.)
Pregnancy and Pain
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.